British Approved Name

Short description: Official name given to pharmaceutical substances

A British Approved Name (BAN) is the official, non-proprietary, or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP).[1] The BAN is also the official name used in some countries around the world, because starting in 1953, proposed new names were evaluated by a panel of experts from WHO in conjunction with the BP commission to ensure naming consistency worldwide[2] (an effort leading to the International Nonproprietary Name system). There is also a British Approved Name (Modified) (BANM).[3]

## Contents

* 1 Combination preparations
* 2 BAN harmonisation
* 3 See also
* 4 References

## Combination preparations

BANs are unique in that names are assigned for combination preparations as well as single-drug preparations. For example, the BAN co-amoxiclav is assigned to preparations containing amoxicillin and clavulanic acid. Most other pharmacopoeias simply refer to combination products by both ingredients in the preparation, in this example "amoxicillin with clavulanic acid".

The prefix of "co-" is used for many combination drugs, including opioid with paracetamol or aspirin analgesics (e.g., co-codamol, co-codaprin, co-dydramol, co-proxamol); the anti-diarrhoeal, non-analgesic mixture of diphenoxylate and atropine, co-phenotrope (trade name Lomotil); antibiotics (e.g., co-fluampicil and co-trimoxazole); antihypertensives (e.g., co-tenidone); diuretics (e.g., co-amilofruse and co-amilozide); gastrointestinal drugs (e.g., co-danthrusate); and anti-Parkinsonism agents such as co-careldopa, co-beneldopa, and co-cyprindiol.[citation needed]

## BAN harmonisation

European Union legislation from 2001 required harmonisation of the BP with the European Pharmacopoeia (EP), as well as the adoption of International Nonproprietary Names through directives (2001/82/EC[4] and 2001/83/EC,[5] as amended, and 2003/63/EC[6]). Across the EU has meant that, with the notable exception of adrenaline/epinephrine,[7] BANs are now the same as the INNs. For example, the old BAN methicillin was replaced with the current BAN meticillin, matching the INN.

This has resulted in an interesting situation in other countries that use BANs. While the British Pharmacopoeia and BANs are the official pharmacopoeia/names defined by legislation in many of these countries, the former BANs often continue to be used, purportedly because of the difficulty of changeover. Despite the importance of the BP, there appears to be little or no movement in the direction of changing these names. In Australia, the Australian Approved Names are generally the same as BANs, but a few exceptions remain.

## See also

* British Pharmacopoeia
* International English food terms
* Nomenclature
* United States Adopted Name

## References

1. ↑ "Paracetamol - different name in USA?". http://www.irishhealth.com/askdoc.html?q=5703.
2. ↑ Mr Anthony C Cartwright (28 June 2015). The British Pharmacopoeia, 1864 to 2014: Medicines, International Standards and the State. Ashgate Publishing, Ltd.. pp. 155–. ISBN 978-1-4724-2032-9. https://books.google.com/books?id=fw6yCQAAQBAJ&pg=PA155.
3. ↑ "Triclofos" (in en). https://www.drugs.com/international/triclofos.html.
4. ↑ "2001/82/EC"
5. ↑ "2001/83/EC"
6. ↑ "2003/63/EC"
7. ↑ Aronson, JK (19 February 2000). ""Where name and image meet"--the argument for "adrenaline".". BMJ (Clinical Research Ed.) 320 (7233): 506–9. doi:10.1136/bmj.320.7233.506. PMID 10678871.

* v
* t
* e

Pharmaceutical and biotechnology industry in the United Kingdom

* Manufacturing in the United Kingdom
* Economy of the United Kingdom

companies|

| current|

* AAH Pharmaceuticals
* Alliance Boots
* Astex
* AstraZeneca (MedImmune)
* BTG
* Cyclacel
* Dechra Pharmaceuticals
* GE Healthcare
* Genus
* GlaxoSmithKline
* Hikma Pharmaceuticals
* Indivior
* MacFarlan Smith
* Norbrook Group
* Oxford BioMedica
* Pfizer UK
* Phytopharm
* Proximagen
* Shire
* Silence Therapeutics
* TBS GB
* Unipath
* Vectura Group
* Vernalis
* ViiV Healthcare

|

defunct|

* Allen & Hanburys
* Amersham
* Beecham Group
* Cambridge Antibody Technology
* Celltech
* Chiroscience
* Distillers Company
* Fisons
* Glaxo Wellcome
* ICI
* Reliant Pharmaceuticals
* Renovo
* Zeneca

government and
regulatory bodies|

* Commission on Human Medicines
* Department of Health
* European Directorate for the Quality of Medicines
* European Medicines Agency
* Medicines and Healthcare products Regulatory Agency
* National Collaborating Centre for Mental Health
* National Patient Safety Agency
* Pharmaceutical Price Regulation Scheme
* Pharmaceutical Society of Northern Ireland
* General Pharmaceutical Council
* Scottish Medicines Consortium
* Veterinary Medicines Directorate

industry and
professional bodies|

* Association of the British Pharmaceutical Industry
* Chemical Industries Association
* European Federation of Biotechnology
* European Federation of Pharmaceutical Industries and Associations
* Faculty of Pharmaceutical Medicine
* Pharmacists' Defence Association
* Royal Pharmaceutical Society of Great Britain
* Worshipful Society of Apothecaries

books and journals|

* Bandolier
* Bad Pharma (2012)
* British National Formulary
* British National Formulary for Children
* Monthly Index of Medical Specialities
* Side Effects (2008)
* The Pharmaceutical Journal

other|

* British Approved Name
* British Pharmacopoeia
* DrugScope
* European and Developing Countries Clinical Trials Partnership
* European Pharmacopoeia
* List of world's largest pharmaceutical companies
* Pharmaceutical Services Negotiating Committee
* Wellcome Trust

* category

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/British Approved Name. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:British_Approved_Name&oldid=4171230"
*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template